A Randomized, Crossover Study Assessing the Effect of EFB0027 on Plasma Glucose and Pharmacokinetics in Subjects With Type 2 Diabetes Mellitus
Phase of Trial: Phase I/II
Latest Information Update: 17 Oct 2016
At a glance
- Drugs Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Elcelyx Therapeutics
- 21 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Mar 2013 New trial record
- 14 Feb 2013 Primary endpoint 'Improved glucose level' has been met, according to an Elcelyx media release.